Eastern Mediterranean (WHO region) vs New Zealand: Treatment success rate for patients treated for MDR-TB
Eastern Mediterranean (WHO region)
75.0%
in 2022
New Zealand
100.0%
in 2022
Eastern Mediterranean (WHO region) rank
4th
New Zealand rank
1st
Treatment success rate for patients treated for MDR-TB over time
- Eastern Mediterranean (WHO region)
- New Zealand
How they compare
New Zealand currently reports 100.0% against 75.0% in Eastern Mediterranean (WHO region), a difference of 25.0%.
That makes New Zealand's figure about 1.3 times Eastern Mediterranean (WHO region)'s.
The two have swapped places 6 times across 17 shared years of data; in 2002 it was New Zealand ahead.
Eastern Mediterranean (WHO region) ranks 4th and New Zealand ranks 1st of 11 groups.
Across the 3 decades both report, Eastern Mediterranean (WHO region) averaged higher in 1 and New Zealand in 2.
Head to head by decade
| Decade | Eastern Mediterranean (WHO region) | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 53.5% | 48.2% | 5.2% | Eastern Mediterranean (WHO region) |
| 2010s | 65.0% | 66.6% | 1.6% | New Zealand |
| 2020s | 74.0% | 100.0% | 26.0% | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Eastern Mediterranean (WHO region) or New Zealand?
- New Zealand, at 100.0% against 75.0% in Eastern Mediterranean (WHO region) as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Eastern Mediterranean (WHO region) and New Zealand?
- 25.0%, with New Zealand ahead.
- How many years of comparable data are there for Eastern Mediterranean (WHO region) and New Zealand?
- 17 years are reported by both, from 2002 to 2022.
- How do Eastern Mediterranean (WHO region) and New Zealand rank globally for treatment success rate for patients treated for mdr-tb?
- Eastern Mediterranean (WHO region) ranks 4th and New Zealand ranks 1st of 11 groups.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.